RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Qing Li to Cyclin-Dependent Kinase Inhibitor p21

Back to Details
This is a "connection" page, showing publications Qing Li has written about Cyclin-Dependent Kinase Inhibitor p21.
Qing Li
Connection Strength
0.030
Cyclin-Dependent Kinase Inhibitor p21
  1. Wu J, Li QQ, Zhou H, Lu Y, Li JM, Ma Y, Wang L, Fu T, Gong X, Weintraub M, Wu S, Ding H. Selective tumor cell killing by triptolide in p53 wild-type and p53 mutant ovarian carcinomas. Med Oncol. 2014 Jul; 31(7):14.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support